F
Fabrizio Romano
Researcher at University of Milano-Bicocca
Publications - 219
Citations - 3509
Fabrizio Romano is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 28, co-authored 193 publications receiving 3004 citations. Previous affiliations of Fabrizio Romano include University of Milan.
Papers
More filters
Journal ArticleDOI
Surgical Treatment of Metastatic Tumors to the Pancreas: A Single Center Experience and Review of the Literature
Stefano Crippa,Carlo Angelini,Chiara Mussi,Claudia Bonardi,Fabrizio Romano,Paola Sartori,Franco Uggeri,Giorgio Bovo +7 more
TL;DR: Surgical resection can be performed safely in selected patients with isolated metastases to the pancreas, achieving long-term survival as well as good palliation, even if not statistically significant.
Journal ArticleDOI
Validation of the Geant4 electromagnetic photon cross-sections for elements and compounds
TL;DR: The Geant4 toolkit as mentioned in this paper provides a wide set of alternative models to describe the electromagnetic interaction of photons with matter, and the photon cross-sections that are used by the geant4 electromagnetic models have been compared to external reference libraries (NIST, EPDL97, SANDIA) for several elements and compounds.
Journal ArticleDOI
Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
Mattia Garancini,Paolo Goffredo,Fabio Pagni,Fabrizio Romano,Sanziana A. Roman,Julie Ann Sosa,Vittorio Giardini +6 more
TL;DR: cHCC‐CC patients appear to have intermediate demographic, clinical, and survival characteristics in comparison with HCC and CC patients, and MJH may be considered the best therapeutic approach for such patients.
Journal ArticleDOI
Ligasure versus Ultracision® in thyroid surgery: a prospective randomized study
Paola Sartori,Sergio De Fina,Giovanni Colombo,Francesco Pugliese,Fabrizio Romano,Giovanni Cesana,Franco Uggeri +6 more
TL;DR: According to the experience, the only real advantage of new hemostatic technologies was a shorter operation time with HS, which was significantly shorter than conventional technique.
Journal ArticleDOI
Prophylaxis against HCV recurrence after liver transplantation: Effect of interferon and ribavirin combination
Vincenzo Mazzaferro,Enrico Regalia,A. Pulvirenti,Alessandro Tagger,Salvatore Andreola,M. Pasquali,D. Baratti,Fabrizio Romano,U. Palazzo,Massimo Zuin,Ferruccio Bonino,Maria Lisa Ribero,Leandro Gennari +12 more
TL;DR: A therapeutic attempt to prevent recurrent HCV infection was undertaken in a group of HCV-RNA positive transplant recipients, using a combination of interferon and ribavirin early after OLT, the first of its kind.